Market-Moving News for September 1st
LABT: 43% | Lakewood-Amedex Biotherapeutics shares are trading higher after the company received a notice of allowance for a U.S. patent titled "ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF" PXS: 23%
Lakewood-Amedex got official permission from the U.S. government to own a patent—like getting a special license—for their antimicrobial (germ-fighting) invention. When a company gets a patent approved, it often means their new idea is real progress, so people get excited and buy more shares.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.